Sonnet BioTherapeutics Holdings, Inc.
Hedge Funds Holdings

Last updated:

Sonnet BioTherapeutics Holdings, Inc.‘s stocks are currently a part of 7 hedge funds’ portfolios, which represents 18.58% of the total amount of its stocks outstanding. This makes up a total of 800.13K shares of Sonnet BioTherapeutics Holdings, Inc.. Compared to the previous quarter, the number grew by 511.30% or 669.24K shares more. As for the holding position changes, 14.29% (1) of current hedge fund investors increased the number of shares held, 14.29% (1) of current holders sold a part of the shares held, and 42.86% (3) closed the holdings completely. 2 hedge funds are new holders of Sonnet BioTherapeutics Holdings, Inc. stock in Q1 2023, it is 28.57% of total holders.

Hedge funds holding Sonnet BioTherapeutics Holdings (Q2 2020 – Q1 2023)

Number of hedge funds
Q2 2020 4
Q3 2020 10
Q4 2020 9
Q1 2021 15
Q2 2021 10
Q3 2021 13
Q4 2021 16
Q1 2022 20
Q2 2022 18
Q3 2022 8
Q4 2022 13
Q1 2023 7

Hedge funds changes in Sonnet BioTherapeutics Holdings positions (Q2 2020 – Q1 2023)

Changes in positions
Q2 2020 40000
Q3 2020 7121-1
Q4 2020 6307-7
Q1 2021 73113
Q2 2021 2217-2
Q3 2021 42115
Q4 2021 35107
Q1 2022 85331
Q2 2022 16641
Q3 2022 71017-17
Q4 2022 7322-1
Q1 2023 21130

Top 50 hedge fund holders of Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN)